10-Q: Altria Group Reports Third Quarter 2024 Results, Announces Cost-Saving Initiative

Altria Group's third quarter results show a mixed performance with increased earnings per share but a decrease in revenue, alongside the announcement of a new cost-saving initiative.

Summary

• Altria Group's third quarter 2024 net earnings increased to $2.293 billion, or $1.34 per share, compared to $2.166 billion, or $1.22 per share, in the same period last year.
• Net revenues for the quarter decreased slightly to $6.259 billion from $6.281 billion in the prior year.
• The company announced a multi-phase 'Optimize & Accelerate' initiative expected to deliver at least $600 million in cumulative cost savings over the next five years.
• The initiative includes centralizing work, streamlining processes, and using AI and automation.
• Altria's smokeable products segment saw a decrease in net revenues, while the oral tobacco products segment experienced an increase.
• The company's adjusted diluted EPS for the quarter was $1.38, compared to $1.28 in the same period last year.
• Altria's Board of Directors approved a 4.1% increase in the quarterly dividend rate to $1.02 per share.
• The company repurchased 13.5 million shares of its common stock for $680 million during the quarter.
• Altria recorded a non-cash, pre-tax impairment of the Skoal trademark of $354 million during the second quarter of 2024.
• The company expects to record charges of approximately $100 million to $125 million related to the initial phases of the 'Optimize & Accelerate' initiative.

Sentiment

Score: 6

Explanation: The document presents a mixed picture with positive aspects like increased EPS and a cost-saving initiative, but also negative aspects like decreased revenue and a significant impairment charge. The overall sentiment is neutral to slightly positive.

Positives

• Net earnings and adjusted diluted EPS increased year-over-year.
• The 'Optimize & Accelerate' initiative is expected to generate significant cost savings.
• The quarterly dividend rate was increased by 4.1%.
• The company continues to repurchase shares, reducing the number of outstanding shares.
• NJOY's share of the e-vapor category reached 6.2% in the third quarter of 2024, an increase of 0.8 share points sequentially.
• on! maintained year-over-year share momentum through the third quarter of 2024 to achieve 8.9% of the total oral tobacco category.

Negatives

• Net revenues decreased slightly compared to the same period last year.
• The smokeable products segment experienced a decrease in net revenues.
• The company recorded a $354 million non-cash impairment of the Skoal trademark.
• The company expects to record charges of approximately $100 million to $125 million related to the initial phases of the 'Optimize & Accelerate' initiative.
• The cigarette industry volume decline for the third quarter of 2024 was primarily driven by the growth of illicit e-vapor products and continued discretionary income pressures on adult tobacco consumers.

Risks

• The company faces ongoing litigation and regulatory challenges.
• The growth of illicit e-vapor products is impacting cigarette sales.
• Discretionary income pressures on adult tobacco consumers are influencing purchasing behaviors.
• The company is subject to potential adverse changes in prices, availability and quality of tobacco, other raw materials and component parts.
• The company is exposed to potential losses in the event of non-performance by counterparties to foreign currency contracts.
• The company is subject to the risk of potential future impairments of intangible assets.
• The company is subject to the risk of potential adverse outcomes in patent infringement lawsuits related to NJOY products.

Future Outlook

Altria expects to complete its $3.4 billion share repurchase program by December 31, 2024, and anticipates the 'Optimize & Accelerate' initiative will deliver at least $600 million in cumulative cost savings over the next five years, which will be reinvested in the business.

Management Comments

• The company is focused on 'Moving Beyond Smoking' and transitioning adult smokers to potentially less harmful choices.
• The 'Optimize & Accelerate' initiative is designed to modernize ways of working and accelerate progress toward the company's Vision and 2028 Goals.
• Management believes that the company's cash and cash equivalents balance, along with future cash flows, provide sufficient liquidity to meet business needs.

Industry Context

The tobacco industry is facing challenges including declining cigarette consumption, the rise of illicit e-vapor products, and evolving consumer preferences. Altria is responding by investing in smoke-free alternatives and implementing cost-saving measures.

Comparison to Industry Standards

• Altria's performance in the cigarette market is being impacted by the same trends affecting other major tobacco companies, including declining volume and increased competition from alternative nicotine products.
• The company's investment in NJOY is a strategic move to compete in the growing e-vapor market, similar to other tobacco companies diversifying their portfolios.
• The cost-saving initiative is a common strategy among large corporations to improve efficiency and profitability, and is similar to actions taken by other companies in the consumer goods sector.
• Altria's share repurchase program is a common practice among publicly traded companies to return value to shareholders, and is similar to actions taken by other companies in the consumer goods sector.
• The company's dividend increase is consistent with its stated goal of providing a progressive dividend, which is a common practice among mature companies to attract investors.

Legal Proceedings

• The company is involved in various legal proceedings, including product liability, unfair trade practices, antitrust, and patent infringement cases.
• Altria is a defendant in a number of e-vapor product lawsuits, including class actions and patent infringement cases.
• The company is also involved in litigation related to its former investment in JUUL.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and share repurchase program.
• Employees may be affected by the 'Optimize & Accelerate' initiative, which includes potential job reductions.
• Customers may see changes in product availability and pricing due to regulatory actions and market conditions.
• Suppliers may be impacted by changes in demand and sourcing strategies.
• Creditors are exposed to the company's debt obligations and potential litigation risks.

Next Steps

• The company will continue to execute on its 'Optimize & Accelerate' initiative.
• Altria will continue to monitor and respond to changes in consumer preferences and market conditions.
• The company will continue to engage with the FDA on regulatory matters.
• Altria will continue to pursue its 2028 Enterprise Goals.

Key Dates

Keywords

Altria, tobacco, e-vapor, nicotine pouches, financial results, cost savings, share repurchase, dividends, NJOY, oral tobacco, smokeable products, illicit trade, FDA, regulation